VIRAL HEPATITIS IN KAZAKHSTAN: REGIONAL EPIDEMIOLOGICAL OVERVIEW
Introduction. Viral hepatitis remains a pressing public health concern worldwide. Like many other countries, Kazakhstan faces various epidemiological challenges associated with both acute and chronic forms of hepatitis A, B, and C.
Aim. To assess the epidemiological situation of viral hepatitis in Kazakhstan, trace the dynamics of incidence from 2000 to 2023, and identify the most vulnerable regions, with a specific focus on the city of Shymkent.
Materials and Methods. A retrospective study was conducted using official statistics from the Ministry of Health of the Republic of Kazakhstan for the years 2000, 2011, and 2023. Data for the city of Shymkent were analyzed for the period from 2018 to 2024. Descriptive and analytical methods were employed, including the calculation of incidence rates, mean values, confidence intervals, and growth rates.
Results. The overall incidence of viral hepatitis in Kazakhstan decreased from 185.6 per 100,000 population in 2000 to 10.23 in 2023. The most significant reductions were observed in the Turkestan, Mangystau, and Kyzylorda regions. However, a resurgence in incidence has been noted in recent years, particularly for hepatitis A and chronic forms of hepatitis B and C. A sharp increase in acute hepatitis A cases was recorded in Shymkent in 2024. Chronic hepatitis C predominates among all chronic forms.
Conclusion. Despite notable progress in combating viral hepatitis, the risk of renewed increases in incidence remains. Enhanced preventive measures are required, including adult vaccination, improved access to treatment, and public health education initiatives to ensure sustainable control of the situation.
Dariyana M. Kulmirzayeva - PhD, Associate Professor of the «Hygiene and Epidemiology» department, South Kazakhstan Medical Academy, Shymkent, Kazakhstan, e-mail: dariyana.kulmirzayeva@gmail.com, https://orcid.org/0000-0001-8174-0171;
Zaurekul I. Beisembayeva - Candidate of Medical Sciences, Acting Associate Professor of the «Hygiene and Epidemiology» department, South Kazakhstan Medical Academy, Shymkent, Kazakhstan, e-mail: igorovna.z@mail.ru, https://orcid.org/0009-0009-3542-8422
Parkhat D. Utepov - Candidate of Medical Sciences, Acting Associate Professor, head of «Hygiene and Epidemiology» department, South Kazakhstan Medical Academy, Shymkent, Kazakhstan, e-mail: utepov.parkhat@mail.ru, https://orcid.org/0009-0001-3924-0664
1. Бюро Национального статистического агентства по стратегическому планированию и реформам Республики Казахстан. Статистика здравоохранения и социального обеспечения. https://stat.gov.kz/en/industries/social-statistics/stat-medicine/ (Дата обращения 05.01.2025)
2. Постановление Правительства Республики Казахстан от 24 сентября 2020 года № 612. Об утверждении перечня заболеваний, против которых проводятся обязательные профилактические прививки в пределах гарантированного объема медицинской помощи, правил, сроков и групп населения, подлежащих профилактическим прививкам Available from: https://adilet.zan.kz/eng/docs/P2000000612 (Дата обращения 06.01.2025)
3. Применение методов статистического анализа для изучения общественного здоровья и здравоохранения. М. ГЭО ТАР-Медиа, 2011. 256 с.
4. Andani A., et al. Evolution and Impact of Hepatitis A Epidemiology in Europe—Systematic Literature Review of the Last 20 Years. Journal of Viral Hepatitis. 2024 Nov 11;32(1):e14030. doi: 10.1111/jvh.14030
5. Andani A. et al. Hepatitis A epidemiology in Latin American countries: a 2020 view from a systematic literature review. Expert review of vaccines. 2020. № 19 (9). pp. 795–805. DOI: 10.1080/14760584.2020.1813575
6. Ashimkhanova A. et al. Epidemiological Characteristics of Chronic Viral Hepatitis in Kazakhstan: Data from Unified Nationwide Electronic Healthcare System 2014-2019. Infect Drug Resist. 2022. № 15. pp. 3333–3346. DOI: 10.2147/IDR.S363609
7. Blach S. et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. The lancet. Gastroenterology and Hepatology. 2017. № 2 (3). pp. 161-176. DOI: 10.1016/S2468-1253(16)30181-9
8. Cheung A., Kwo P. Viral Hepatitis Other than A, B, and C: Evaluation and Management. Clinics in Liver Disease. 2020. № 24. pp. 405-419. DOI: 10.1016/j.cld.2020.04.008
9. Fiore A.E., Wasley A., Bell B.P. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and report: morbidity and mortality weekly report. Recommendations and reports. 2006. № 55 (RR-7). pp. 1-23.
10. Igissinov N. et al. Epidemiological aspects of hepatitis B and C markers in blood donors in Kazakhstan; 2000-2011. Iranian Journal of Public Health. 2014. № 43 (2). pp. 156-161.
11. Jacobsen K.H., Wiersma S.T. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010. № 28 (41). pp. 6653-6657. DOI: 10.1016/j.vaccine.2010.08.037
12. Jumabayeva A., Nersesov A., Kulzhanov M. Prevalence of Viral Hepatitis B.C., and D in Kazakhstan. Scientific World Journal. 2022. Article ID 9102565. DOI: 10.1155/2022/9102565
13. Krebs L.S. et al. Shifting susceptibility to hepatitis A among children and adolescents over the past decade. Journal of pediatria. 2011. № 87 (3). pp. 213-218. DOI: 10.2223/JPED.2088
14. Lemoine M., Nayagam S., Thursz M. Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges. Future virology. 2013. № 8(4). pp. 371-380. DOI: 10.2217/fvl.13.11
15. Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. The Lancet Gastroenterology & Hepatology. 2018. № 3 (6). pp. 383-403. DOI: 10.1016/S2468-1253(18)30056-6
16. Pisano M.B., et al. Viral hepatitis update: Progress and perspectives. World Journal of Gastroenterology. 2021. № 27 (26). pp. 4018-4044. DOI: 10.3748/wjg.v27.i26.4018
17. Rein D.B. et al. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012. № 55. pp. 988–997. DOI: 10.1002/hep.25505
18. Schweitzer A., Horn J., Mikolajczyk R.T. et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review. The Lancet. 2015. № 386 (10003). pp. 1546–1555. DOI: 10.1016/S0140-6736(15)61412-X
19. Stanaway J.D. et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. The Lancet. 2016. № 388 (10049). pp. 1081-1088. doi: 10.2147/IDR.S363609
20. Stockdale A.J. et al. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. Journal of hepatology. 2020. № 73 (3). pp. 523–532. DOI: 10.1016/j.jhep.2020.04.008
21. World Health Organization. WHO Global Hepatitis Report. World Health Organization. 2022. Global Health Sector Strategy on Viral Hepatitis 2016-2021. Available from: https://iris.who.int/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf (accessed: 06.01.2025)
22. World Health Organization. Immunization, Vaccines and Biologicals: Hepatitis A. Hepatitis A vaccines: WHO position paper. Weekly Epidemiological Record. 2022. vol. 97, 40. Available from: https://www.who.int/teams/immunization-vaccines-and-biologicals/policies/position-papers/hepatitis-a (accessed: 06.01.2025)
23. World Health Organization. WHO Global Hepatitis Report. 2024. Available from: https://iris.who.int/bitstream/handle/10665/376409/B09024-eng.pdf (accessed: 06.01.2025)
24. World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections. WHO. 2021. Available from: https://www.who.int/publications/i/item/9789240027077 (accessed: 06.01.2025)
25. World Health Organization. Hepatitis B and C. WHO fact sheets. Updated April 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b(accessed: 06.01.2025)
26. World Health Organization. Hepatitis A fact sheet. Updated February 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-a (accessed: 06.01.2025)
Количество просмотров: 116
Категория статей:
Оригинальное исследование
Библиографическая ссылка
Kulmirzayeva D.M., Beisembayeva Z.I., Utepov P.D. Viral hepatitis in Kazakhstan: regional epidemiological overview // Nauka i Zdravookhranenie [Science & Healthcare]. 2025. Vol.27 (2), pp. 7-14. doi 10.34689/SH.2025.27.2.001Похожие публикации:
VIRAL HEPATITIS IN KAZAKHSTAN: REGIONAL EPIDEMIOLOGICAL OVERVIEW
PREDICTORS OF ANTIVIRAL THERAPY INEFFECTIVENESS IN CHRONIC HEPATITIS C: A MATCHED CASE-CONTROL STUDY IN ALMATY, A MAJOR METROPOLIS OF KAZAKHSTAN
МЕДИКО – СОЦИАЛЬНЫЕ ОСОБЕННОСТИ ПРИВЕРЖЕННОСТИ К ЛЕЧЕНИЮ БОЛЬНЫХ С ХРОНИЧЕСКИМ ПАНКРЕАТИТОМ
PATHOGENETIC ASSESSMENT OF CLINICAL AND INSTRUMENTAL PARAMETERS OF THE LUNGS IN PATIENTS WITH DIABETES MELLITUS
THE FREQUENCY AND EFFICACY ASSESSMENT OF RADIOIODINE THERAPY FOR DISTANT METASTASES OF THYROID CANCER